Ovarian cancer
Conditions
Interventions
Case series:None
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Signed Informed Consent Form (ICF) 2. Age = 18 years 3. Has histologically confirmed diagnosis of advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer 4. high grade serous adenocarcinoma or endometrioid adenocarcinoma; 5. First-line platinum-containing chemotherapy or platinum-sensitive patients with platinum-based chemotherapy after the use of PARP inhibitor maintenance treatment;
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following conditions should not be enrolled in this clinical study: (1) Histopathology indicating low-grade serous adenocarcinoma, mucinous adenocarcinoma, or carcinosarcoma; (2) Patients with concomitant primary tumors; (3) Concurrent use of other antitumor drugs; (4) Pregnant women; (5) HIV positive; (6) Deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse events; | — |
Countries
China
Contacts
Public ContactLan Chunyan
Sun Yat-sen University Cancer Center
Outcome results
None listed